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ABSTRACT
Objectives: The serum zinc and platelet statuses of sickle cell patients attending General Hospital, Owerri, Nigeria, were investigated.
Methods: Fifty confirmed sickle cell patients (hemoglobin [Hb]SS) age 10–30 years were selected. Fifty normal subjects (HbAA) age 10–30 years were 
used as control. The zinc and platelets were determined using standard methods.
Results: The levels of serum zinc, selenium, and platelet were significantly decreased in sickle cell anemia (p<0.05) when compared with the control.
Conclusion: The result suggests that supplementation of sickle cell patients with food and drug-containing zinc might be helpful, particularly in 
wound healing, as zinc positively correlates with platelet counts. These low zinc, selenium, and platelets could represent a risk for sickle cell anemia.
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INTRODUCTION
Sickle cell anemia is a genetic disease that affects majorly African 
countries [1]. It is characterized by a point mutation in the 
β-hemoglobin (Hb) gene, leading to the synthesis of sickle Hb (HbS), 
which polymerizes when deoxygenated, distorting, and injuring the 
red blood cell (RBC). It occurs more often among people from parts 
of the world where malaria is common [2,3]. Africa is the area of the 
world most threatened by malaria, particularly Nigeria, because it has 
the most efficient vectors, the Anopheles gambiae complex [4]. Sickle 
cell trait or disease offers a protective effect against malaria. In sickle 
cell anemia, the normal round shape of RBCs becomes like crescent 
moons [5,6]. The role of RBCs is to deliver oxygen to the body. In sickle 
cell anemia, there is abnormal Hb, called sickle Hb or HbS. This results 
to RBCs losing its ability to last long because the sickle Hb destroys 
them [7,8].
Zinc is a trace element and is majorly abundant trace element next to 
iron in nature [9]. It is an important component of metalloproteins, 
which has a role in maintaining antioxidant activity, cellular immunity, 
and immunological integrity. Sickle cell anemia patients may show 
hypogonadism, mental lethargy, delayed wound healing growth 
retardation, cell-mediated immune dysfunctions, and abnormal 
neurosensory changes, which may be due to inadequate zinc [10,11].
Selenium plays an essential role in the health of the immune system. This 
antioxidant aids to reduce oxidative stress in the body, which lowers 
inflammation and improves immunity. Increased levels of selenium 
could be beneficial for boosting the immune system in patients with 
some disorders like inflammation [12].
In sickle cell anemia, platelet is affected. Platelet is a tiny blood cell that 
helps the body form clots to stop bleeding. If one of the blood vessels 
gets damaged, it sends out signals to the platelets. The platelets then 
rush to the site of damage. They form a plug (clot) to fix the damage [13]. 
The main function of platelets includes the maintenance of hemostasis, 
which depends on three of their properties, the endothelial supporting 
function of platelets, and the ability to form hemostatic plugs and to 
release lipoprotein material [14].
In this study, the level of zinc and platelet in sickle cell anemia patients 
was determined to provide information on their status in Owerri, Imo 
State, Nigeria.
METHODS
Thirty HbSS diagnosed by hemoglobin electrophoresis (25 males 
and 25 females) aged 10–30 years were selected for the study. These 
patients were attending General Hospital, Owerri. Fifty HbAA normal 
subjects (25 males and 25 females) were used as control.
Blood sample
In all subjects, 4 ml of venous blood was collected into plain and 
ethylenediaminetetraacetic acid bottle. The samples were spun in a 
Wisterfuge centrifuge (model 684) at 1000 g for 10 min and the serum 
collected into bijou bottle. Informed consent of the participants was 
obtained and was conducted in line with the ethical approval of the 
hospital.
Biochemical assay
The serum zinc and selenium were determined by atomic absorption 
spectrophotometric method [15], while the platelet was determined 
using standard method.
Statistical analysis
The results were expressed as mean±standard deviation. Statistical 
significance was calculated using Student’s t-test. The level of 
significance was calculated at p<0.05.
RESULTS
 The results of the levels of zinc, selenium and platelet in HbSS and 
HbAA are indicated below: 
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The result from Table 1 shows that the levels of zinc, selenium and 
platelet were significantly decreased in HbSS when compared with 
HbAA at p<0.05.
DISCUSSION
Sickle cell anemia is an inherited disorder characterized by a high 
potential for oxidative damage due to a chronic redox imbalance 
in red cells which leads to continuous production of reactive 
oxygen species (ROS) and clinical manifestations of mild-to-severe 
hemolysis [16]. In this study, there are significantly lower plasma 
levels of zinc and platelets in sickle cell anemia. Since patients with 
sickle cell anemia are under continuous oxidative stress due to sickle 
cell lipid peroxidation, a deficiency in zinc may lead to sickle cell 
manifestations. Some pathological effects of zinc insufficiency include 
the occurrence of skin lesions, growth retardation, impaired immune 
function, and compromised would healing as can be observed in 
sickle cell anemia. The generation of ROS can be grossly amplified 
in response to a variety of pathophysiological conditions such as 
deficiency in antioxidant, dehydration, hypoxia, inflammation, and 
infection. ROS generation in RBCs of sickle cell anemia patients 
could be linked to HbS auto-oxidation and potentially aberrant 
mitochondrial function [17]. The decrease in zinc could be linked 
to non-absorption from the diet due to excess copper or iron which 
interferes with absorption. This is in line with the work of Nnodim 
et al. [18].
In spite of a good diet, sickle cell anemia patients may have an 
inadequate intake of zinc due to chronic pain, reduced appetite, and 
hemolysis. The reduction in zinc could be linked to increased demand 
and consumption as well as increased urinary excretion due to impaired 
renal concentration and hypoxanthinuria [18,19]. This is in line with 
the work of Lassi et al. [20].
Selenium level was observed to be significantly decreased when 
compared with the control. Selenium plays a crucial role as a cofactor 
for the reduction of an antioxidant enzyme such as glutathione 
peroxidase, an enzyme which aids react with potentially harmful 
oxidizing agents in substances. Therefore, the reduction of selenium in 
sickle cell may probably create an oxidative stress, leading to vascular 
occlusion in sickle cell patients. This, in other words, may seemingly 
result in sickle cell crisis. Low plasma selenium levels observed in this 
study may also suggest that a weakened antioxidant potential may be 
associated with sickle cell disease patients. This is in line with the work 
of Nnodim et al. [12].
Similarly, the level of platelet was significantly reduced. Abnormal 
platelet counts are relatively common in sickle cell patients suffering 
from different types of complications. A production defect could 
result from vaso-occlusive marrow infarction or sepsis. Second, 
sickle cell-endothelial interaction results in coagulation factor 
activation and a state of compensated disseminated intravascular 
coagulation with platelet consumption. This situation is aggravated 
in crisis [21].
CONCLUSION
These low zinc, selenium, and platelets could represent a risk for sickle 
cell anemia.
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Table 1: Zinc, selenium, and platelet in HbAA and HbSS
Parameters HbAA HbSS
Zinc (μ/L) 135.41±6.6 97.58±8.4
Selenium (μ/dl) 65.40±7.5 53.97±8.6
Platelet (μL) 310.000±25 227.000±35
*Significantly different from control at p<0.05. The levels of zinc, selenium, and 
platelet were decreased in HbAA/when compared with the HbSS at p<0.05. 
Hb: Hemoglobin
